Richard is a Partner at Sinovation Disrupt Fund, a $500 million technology fund focusing on growth investments. Previously, he was with Sinovation's venture funds as an advisor and then a Partner from 2015 to 2021. He has 18 years of experience in technology entrepreneurship and investments.

Richard focuses on the technologies and services in health and productivity sectors worldwide. He manages an active portfolio of 30+ companies such as Meditrust 镁信健康, Insilico Medicine 英矽智能, XAG 极飞, Megarobo 镁伽, and Glinx 基灵.

Richard graduated from Washington University in St. Louis with a Bachelor of Science in Business Administration. His passion is working with talented founders and teams, applying social and historical studies to investments, and supporting charities in children's and women's rights.